Oruka Therapeutics ORKA Q4 2025 narrower than expected loss pushes shares up two percent on positive investor sentiment Why is Evertec EVTC stock gaining attention recently 010 20260420 RYTM Rhythm Pharmaceuticals tops Q4 2025 EPS estimates posts 458 percent yearoveryear revenue growth shares dip 109 percent